These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27030511)

  • 1. Structure Based Docking and Molecular Dynamic Studies of Plasmodial Cysteine Proteases against a South African Natural Compound and its Analogs.
    Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö
    Sci Rep; 2016 Mar; 6():23690. PubMed ID: 27030511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. South African Abietane Diterpenoids and Their Analogs as Potential Antimalarials: Novel Insights from Hybrid Computational Approaches.
    Musyoka T; Bishop ÖT
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31703388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Thillainayagam M; Malathi K; Ramaiah S
    J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design.
    Musyoka TM; Njuguna JN; Tastan Bishop Ö
    Malar J; 2019 May; 18(1):159. PubMed ID: 31053072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures.
    Hernández-González JE; Salas-Sarduy E; Hernández Ramírez LF; Pascual MJ; Álvarez DE; Pabón A; Leite VBP; Pascutti PG; Valiente PA
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2911-2923. PubMed ID: 30253205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.
    Wang L; Zhang S; Zhu J; Zhu L; Liu X; Shan L; Huang J; Zhang W; Li H
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1261-4. PubMed ID: 24530004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow.
    Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö
    J Biomol Struct Dyn; 2016 Oct; 34(10):2084-101. PubMed ID: 26471975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
    Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
    Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
    Thillainayagam M; Anbarasu A; Ramaiah S
    J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.
    Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA
    J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of α-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum.
    Weldon DJ; Shah F; Chittiboyina AG; Sheri A; Chada RR; Gut J; Rosenthal PJ; Shivakumar D; Sherman W; Desai P; Jung JC; Avery MA
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1274-9. PubMed ID: 24507921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors.
    Liu Y; Lu WQ; Cui KQ; Luo W; Wang J; Guo C
    Arch Pharm Res; 2012 Sep; 35(9):1525-31. PubMed ID: 23054708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies.
    Sabnis YA; Desai PV; Rosenthal PJ; Avery MA
    Protein Sci; 2003 Mar; 12(3):501-9. PubMed ID: 12592020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
    Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
    J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
    Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
    Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug target prioritization in Plasmodium falciparum through metabolic network analysis, and inhibitor designing using virtual screening and docking approach.
    Yadav MK; Pandey SK; Swati D
    J Bioinform Comput Biol; 2013 Aug; 11(4):1350003. PubMed ID: 23859267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antimalarial activity in vitro, and docking studies of novel neolignan derivatives.
    Pereira GAN; Souza GC; Santos LS; Barata LES; Meneses CCF; Krettli AU; Daniel-Ribeiro CT; Alves CN
    Chem Biol Drug Des; 2017 Sep; 90(3):464-472. PubMed ID: 28245094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.